Americas hospitals and health systems are deeply concerned about Aetnas recently announced level of severity inpatient payment policy.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
Hospitals and health systems are experiencing significant financial pressures that challenge their ability to provide 24/7 care for the patients and communities they serve. As Congress begins to focus on its end-of-the-year work, Americas hospitals and health systems respectfully request that you consider the following priorities.
RE: CMS1832P Medicare and Medicaid Programs; Calendar Year 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
September 11, 2025
AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B rebate models.
AHA asks Majority Leader Thune, Leader Schumer, Speaker Johnson and Leader Jeffries to ask you to address the Medicaid disproportionate share hospital (DSH) program reductions scheduled to begin on Oct. 1, 2025.
September 4, 2025
AHA letter to Senators Barrasso and Whitehouse expressing support for the Senate Preserving Patient Access to Accountable Care Act.
AHA letter to Representatives LaHood, DelBene, Dunn and Schrier expressing support for the House Preserving Patient Access to Accountable Care Act.
AHA comments on the Health Resources and Services Administrations notice of the 340B Rebate Model Pilot Program.